National Advisory Council Agenda

147th Meeting of the National Advisory Council on Drug Abuse

Hybrid Meeting – May 7, 2024

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

10:30 a.m.Call to Order
Nora Volkow, M.D.
Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
10:45 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Iván Montoya, M.D., M.P.H., Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Office of Research Training, Diversity, and Disparities
Aria Crump, Sc.D., Deputy Director

11:45 p.m.Break


Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Jeanette Marketon, within ten days of the meeting. Any written statements by members of the public will receive careful consideration.

Join the Videocast.

Open Session

1:00 p.m.Welcome and Opening Remarks
Nora Volkow, M.D., Director, NIDA
1:15 p.m.Director's Report
Nora Volkow, M.D., Director, NIDA
2:00 p.m.Discussion
Council Members
2:30 p.m.National Institute of Drug Abuse Lifetime Achievement Award
William L. Dewey, Ph.D.
Nora Volkow, M.D., Director, NIDA
2:45 p.m.Break
3:00 p.m.The Division of Neuroscience and Behavior: Advancing the Neuroscience of Addiction
Rita Valentino, Ph.D.
Director, Division of Neuroscience and Behavior (DNB)
3:30 p.m.Concept Clearances
4:30 p.m.Public Comments
4:45 p.m.Adjourn